Showing posts with label side effects humira. Show all posts
Showing posts with label side effects humira. Show all posts

Thursday, August 23, 2012

Patient Diagnosed w/ Cancer After Humira Treatment - Abbott Labs Lawsuit for Many Claims

Entire Article Below :)    


Reading articles like this one doesn't shock me.  I know everything about these drugs and it's only a matter of time before we start seeing similar sad effects from these horrible toxic drugs.  Watch....  you will see this happen for yourself as time goes on.  
The effects of the drug are available if you search, and I always take time to read about the drug I plan to be putting in my body.  NEVER trust your doctors word... even if he is the greatest doctor.  You have no idea if your doctor is recommending Humira  (or any other drug for that matter) because they are getting "kick backs" - it's discussed in the article below,  a short definition of the meaning - a KICKBACK is a payment made to someone who has facilitated a transaction or appointment, esp. illicitly.  Illegal Yes, paying physicians money to recommend a drug so sales will increase, is not the correct reason to suggest a treatment.  That's why It's so important to do your homework before saying "yes" to a treatment.  It doesn't matter how many positives your doctor tells  you about and that he told you it is a SAFE option .  

I CANNOT STRESS THIS ENOUGH - Do yourself a huge favor, find out the facts for yourself.


This is how---->  Read non biased information (a biased source -  the pharmaceutical company's website about the drug.  Of course they will shed light on mostly the benefits).  Read information from a reputable source (a peer review journal article, Pubmed (where you can find published research results.  Looking up specific keywords of your choice - Pubmed is linked on my side bar for easy access.).  

Once you've gathered and read through enough information , next weight the positives of taking the medication and the negatives (risks). Are the possible dangers worth it for the condition you have, is there a safer option available,  Have you tried all other treatments for your condition and seem to be hitting a wall in regards to medications thatwill bring you relief. What natural therapies are available to treat the condition, who would be a good candidate to take a medication with dangerous side--effects like Humira (your genetics matter)







Arthritis Drug Humira Blamed for Cancer


 CHICAGO (CN) - Abbott Laboratories' blockbuster arthritis drug Humira gave a woman cancer, she claims in Cook County Court.

     Carolyn and Eric Shaw sued Abbott Laboratories for product liability, product defects, failure to warn, misrepresentation, negligence, breach of warranty and loss of consortium.
     "Plaintiff Carolyn Shaw was prescribed Abbott's blockbuster arthritis drug 'Humira' and received bi-monthly injections from October 2008 to August 2010 when she was diagnosed with B-cell non-Hodgkin's follicular lymphoma. She underwent surgery and chemotherapy treatment, and luckily her cancer went into remission. Unfortunately, she will have to undergo treatments every five months for the rest of her life to ensure the cancer will not return," the complaint states.
     The FDA approved Humira to treat arthritis in December 2002. It is Abbott's best-selling drug, according to the complaint.
     "(I)n 2011, Humira's worldwide sales were $7.9 billion," the Shaws say.
     The complaint states: "the data from Humira clinical trials and other peer-reviewed medical literature show that the rate of malignancies in the group of patients treated with Humira was significantly higher than the rate of malignancies in the group that were treated with placebo. The increased rate of lymphomas was statistically significant. This differential in rate was a significant safety signal. It should have prompted a significant clear warning from Abbott to both physicians and patients about this potential side effect.
     "Although the clinical trial data alone should have prompted both a stringent warning and proactive study, instead of conducting further studies and/or otherwise calling attention to the increased risk of life-threatening side effects front and center in the label, and communicating same to Dr. Suarez [Carolyn Shaw's nonparty rheumatologist] Abbott buried and information regarding malignancies in the label. Further, what 'warning' information was mentioned severely downplayed the risk and confused the issue, consistent with its sales message, in RA [rheumatoid arthritis] data."
     The complaint adds: "It is widely recognized within the pharmaceutical industry that adverse side effects of medication are vastly unreported. The industry accepted rule of thumb is that the MedWatch system captures somewhere between 1 percent and 10 percent of real world events. Therefore, the MedWatch reports put Abbott on notice that, in fact, there were somewhere between 250 and 2,500 real world Humira patients who had experienced Humira-related lymphomas or other malignancies.
     "Because FDA regulations require the drug manufacturer to add a warning - in the warnings section of the label - whenever there is a 'reasonable association' between the drug and a dangerous side effect, and further state that 'a causal relationship need not be established' before a warning is required, this information from the adverse event database should have prompted Abbott to issue strong, clear warnings about the risk of lymphomas and other forms of malignancies due to the use of Humira. But Abbott failed to do so until many years later, when the FDA made them do it."
     The Shaws say: "Not until August 4, 2009 - almost a year after Carolyn Shaw began taking Humira - did Abbott put a black box warning on their label alerting patients and doctors of cases of leukemia, hematological cancer, in adults, adolescents, and children."
     Carolyn Shaw developed an enlarged lymph node in her neck in 2010 and was diagnosed with Stage IIA lymphoma. "When Carolyn and Wayne asked Dr. [Mark] Freidman what he thought caused her lymphoma, his answer was 'Humira,'" the complaint states.
     The Shaws claim that Abbott aggressively markets Humira and makes "widespread use of direct payments to physicians utilized by Abbott to both sell more Humira and increase prescriptions across the country."
     "Needless to say, these financial inducements and payments provide incentives, perhaps on a subconscious level but real nonetheless, to skew the 'informed consent' discussion in favor of the benefits of Humira, at the expense of the risks. More importantly, patents are not aware of these types of 'behind the scenes' payments being made to physicians. ... It most certainly was not disclosed by either Abbott or the prescribing physicians to the individual plaintiff and/or patient."
     Abbott Laboratories is the only defendant. Neither of the Shaws' doctors is a party to the case.
     The Shaws claim that Abbott withheld critical information that would have enabled Carolyn to make an informed decision about whether to take Humira: "Although physicians prescribe medications, it is patients who have the ultimate authority to decide whether to put them into their bodies or not. Because of the dangerous side effects of Humira, it is extremely important that both physicians and patients be fully informed - not only about the potential benefits of the drug, but also about the risks of side effects. Neither Carolyn nor her physicians were warned in any meaningful or legally adequate manner about the risk of lymphoma when she began taking Humira," the Shaws claim.
     The Shaws are represented by Gary McCallister.


Courthouse News Service:

'via Blog this'

Tuesday, June 14, 2011

Permanent Optic Nerve Damage--> Thanks to Humira (aka Biologic Bull****)


I should probably create a page (when I make pages) that's titles "Lawsuits Due to Biologic Treatments".  This is like the 4th or 5th article i've posted in regards to biologic drugs producing long-term damage to someone.

The last paragraph of this article gets me.   "...Abbott downplayed the risk of Humira side effects, including the risk of Central Nervous System (CNS) demyelination, which can cause optic neuritis, transverse myelitis, multiple sclerosis or other nerve problems."  These aren't minor side-effects like dry mouth, these conditions will impact your life dramatically and forever.


 I wonder what other health risks Abbott Labs have downplayed.  Adding the nerve damage issues would just be a few more health problems that you risk developing by treatment with these biologic meds.  LOL when the freaking side-effect profile lists almost 100 possible negative consequences that may happen to you if your lucky, what's 105.  People must really be desensitized OR maybe patients trust their doctor and are completely clueless.  Unfortunately, to know all the important details of something, requires effort on your part.  You have to do your own research - Trust no one
___________________________________________________________


Vision Problems from Humira Result in Lawsuit Over Optic Nerve Damage - AboutLawsuits.com

Abbott Laboratories faces a product liability lawsuit over Humira, their blockbuster arthritis and Crohn’s Disease drug, which was filed by a woman who alleges that she has developed optic nerve damage and permanent vision problems from Humira.
The Humira lawsuit was filed by Jamie Bixby in the U.S. District Court for the Northern District of Illinois on May 20, 2011.
Bixby alleges that side effects of Humira caused her to develop optic neuritis, an inflammation of the optic nerve that has left her with permanent impairment to vision in her left eye and a future risk of other nerve problems, including multiple sclerosis or loss of vision in her other eye.
Humira (adalimumab) is a “biologic” drug, which is part of a class of medications known as TNF blockers or tumor necrosis factor blockers. The medication was launched by Abbott Laboratories in 2003 for treatment of rheumatoid arthritis, but was subsequently approved for other indications, including treatment of Crohn’s Disease.
According to allegations raised in the complaint, Abbott downplayed the potential risk of Humira vision problems, despite the fact that information was available to establish notice that the drug may increase the risk of optic neuritis and other nerve damage from central nervous system (CNS) demyelination.
Bixby began using Humira in April 2008 for treatment of Crohn’s Disease, after her doctor suggested that the medication may be a better option than the long-term use of the steroid prednisone, which had been managing her symptoms. No warnings were provided on the drug label or prescription information that Humira may cause permanent damage to her vision at the time she began taking the medication.
In May 2008, Bixby indicates that she began experiencing severe headaches and pain in her left eye, which led her to call the toll free number provided with her Humira packet to ask if the problems may be related to the use of Humira. According to allegations contained in the complaint, Abbott’s nurse told her that eye pain was not related to Humira and suggested she contact her physician.
When Bixby contacted her doctor, she was told by the doctor’s office that they were unaware that eye problems were a known issue with Humira and scheduled an appointment for the following week. However, the next day Bixby noticed that the vision in her left eye became blurry with blacked out areas, causing her to leave work and seek immediate medical attention at an eye clinic.
Bixby was diagnosed with optic neuritis from Humira in both eyes, though she only experienced vision problems in her left eye. Following her diagnosis, Bixby was admitted for inpatient treatment to receive 4 days of intravenous steroids.
“Unfortunately, because Abbott had not adequately warned Ms. Bixby or her physician about the risk of optic neuritis, the diagnosis and treatment came too late to prevent permanent vision impairment for Ms. Bixby,” the complaint states.
Bixby previously worked as a web designer, and claims that she continues to suffer from headaches and eye pain that impact her ability to look at a computer screen for significant periods of time. She also continues to suffer blurry vision and black holes in the vision from her left eye, and has extreme light sensitivity and changes to her depth perception that affect her ability to drive or ride a bike.
Plaintiff alleges that Abbott downplayed the risk of Humira side effects, including the risk of Central Nervous System (CNS) demyelination, which can cause optic neuritis, transverse myelitis, multiple sclerosis or other nerve problems.